Cover Image
Market Research Report
Product code 
1002186

Global Recombinant Plasma Protein Therapeutics Market, Size, Share, Opportunities and Forecast, 2020-2027

Published: | DataM Intelligence | 180 Pages | Delivery time: 2 business days

Price

Back to Top
Global Recombinant Plasma Protein Therapeutics Market, Size, Share, Opportunities and Forecast, 2020-2027
Published: April 3, 2021
DataM Intelligence
Content info: 180 Pages
Delivery time: 2 business days
  • ALL
  • Description
  • Table of Contents
Description

Global Recombinant Plasma Protein Therapeutics Market is segmented By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Drug Type (Recombinant Coagulation Factors (Recombinant Coagulation Factor VIII, Recombinant Coagulation Factor IX), Human C1 Esterase Inhibitor), By Cell Line (Chinese Hamster Ovary (CHO) Cell Line, Baby Hamster Kidney (BHK) Cell Line, Human Embryonic Kidney (HEK) Cell Line, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

The Global Recombinant Plasma Protein Therapeutics Market is expected to grow at a CAGR of 8.3% during the forecasting period (2020-2027).

Why Purchase the Report?

Visualize the composition of the Recombinant Plasma Protein Therapeutics Market across each product type and application highlighting the critical commercial assets and players.

Identify commercial opportunities in the Recombinant Plasma Protein Therapeutics Market by analyzing trends and co-development deals.

Comprehensive details on factors driving the market growth.

Excel data sheet with thousands of data points of Recombinant Plasma Protein Therapeutics Market segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Target Audience

Industry Investors/Investment Bankers

Suppliers/Buyers

Education & Research Institutes

Manufacturers

Research Professionals

Emerging Companies

Distributors

Table of Contents

Table of Contents

Table of Contents

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Recombinant Plasma Protein Therapeutics Market Definition and Overview

3. Global Recombinant Plasma Protein Therapeutics Market - Executive Summary

  • 3.1. Market Snippet by Disease Type
  • 3.2. Market Snippet by Drug Type
  • 3.3. Market Snippet by Cell Line
  • 3.4. Market Snippet by Region
  • 3.5. DataM CLO Scenario

4. Global Recombinant Plasma Protein Therapeutics Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in new product launches
      • 4.1.1.2. Rise in awareness about rare disease treatment
      • 4.1.1.3. Increase in investment
      • 4.1.1.4. Rising prevalence of hematological disease
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of treatment
      • 4.1.2.2. Rise in alternative therapies
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Recombinant Plasma Protein Therapeutics Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis

6. Global Recombinant Plasma Protein Therapeutics Market - Epidemiology Analysis

7. Global Recombinant Plasma Protein Therapeutics Market - Pipeline Analysis

8. Global Recombinant Plasma Protein Therapeutics Market - By Disease Type

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
  • 8.3. Market Attractiveness Index, By Disease Type
  • 8.4. Hemophilia A
    • 8.4.1. Introduction
    • 8.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
  • 8.5. Hemophilia B
  • 8.6. Von Willebrand Disease
  • 8.7. Others

9. Global Recombinant Plasma Protein Therapeutics Market - By Drug Type

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
  • 9.3. Market Attractiveness Index, By Drug Type
  • 9.4. Recombinant Coagulation Factors
    • 9.4.1. Introduction
    • 9.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.4.3. Recombinant Coagulation Factor VIII
    • 9.4.4. Recombinant Coagulation Factor IX
  • 9.5. Human C1 Esterase Inhibitor

10. Global Recombinant Plasma Protein Therapeutics Market - By Cell Line

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Line
  • 10.3. Market Attractiveness Index, By Cell Line
  • 10.4. Chinese Hamster Ovary (CHO) Cell Line
    • 10.4.1. Introduction
    • 10.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
  • 10.5. Baby Hamster Kidney (BHK) Cell Line
  • 10.6. Human Embryonic Kidney (HEK) Cell Line
  • 10.7. Others

11. Global Recombinant Plasma Protein Therapeutics Market - By Region

  • 11.1. Introduction
  • 11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 11.3. Market Attractiveness Index, By Region
  • 11.4. North America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Line
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.6.1. U.S.
      • 11.4.6.2. Canada
      • 11.4.6.3. Mexico
  • 11.5. Europe
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Line
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.6.1. Germany
      • 11.5.6.2. U.K.
      • 11.5.6.3. France
      • 11.5.6.4. Italy
      • 11.5.6.5. Spain
      • 11.5.6.6. Rest of Europe
  • 11.6. South America
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Line
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.6.6.1. Brazil
      • 11.6.6.2. Argentina
      • 11.6.6.3. Rest of South America
  • 11.7. Asia-Pacific
    • 11.7.1. Introduction
    • 11.7.2. Key Region-Specific Dynamics
    • 11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Line
    • 11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.7.6.1. China
      • 11.7.6.2. India
      • 11.7.6.3. Japan
      • 11.7.6.4. Australia
      • 11.7.6.5. Rest of Asia Pacific
  • 11.8. Middle East and Africa
    • 11.8.1. Introduction
    • 11.8.2. Key Region-Specific Dynamics
    • 11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cell Line

12. Global Market - Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Competitor Recombinant Plasma Protein Therapeutics Strategy Analysis
  • 12.3. Comparative Product Portfolio Analysis
  • 12.4. Market Positioning/Share Analysis
  • 12.5. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. CSL Limited *
    • 13.1.1.  Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Takeda Pharmaceutical Company Limited
  • 13.3. Octapharma
  • 13.4. Novo Nordisk A/S
  • 13.5. Bayer AG
  • 13.6. Sanofi
  • 13.7. Aptevo Therapeutics
  • 13.8. Pharma Group NV
  • 13.9. Pfizer Inc.
  • 13.10. Viropharma Biologics, Inc.
  • 13.11. Grifols S.A.
  • 13.12. Biotest AG
  • 13.13. Baxter
  • 13.14. Kedrion SPA

14. Global Recombinant Plasma Protein Therapeutics Market - Premium Insights

15. Global Recombinant Plasma Protein Therapeutics Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us